Form 4: Quoin Pharmaceuticals CEO Buys Shares
Insider Transaction (Form 4)
Michael Myers, Chief Executive Officer and a Director of Quoin Pharmaceuticals, Ltd., purchased 30,735 shares of common stock on August 31, 2026 for $4.88 per share.
Summary
- Open-market purchase: acquired 20,490 ADSs at $4.88 ($99,991) on August 31, 2026; holds 37,713 after (Direct).
- Open-market purchase: acquired 10,245 Ordinary Warrants (Right to Buy) on August 31, 2026; holds 10,245 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $99,991, committing personal capital to the stock.
Insider Transactions
Michael Myers — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Open-market purchase | ADSs | 20,490 | $5 | $100.0K | 37,713 |
| 2026-08-31 | Open-market purchase | Ordinary Warrants (Right to Buy) | 10,245 | — | — | 10,245 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Open-market purchase (20,490 shares) |
| 2026-08-31 | Open-market purchase (10,245 shares) |
Keywords
insider transaction, Form 4, QNRX, Quoin Pharmaceuticals, Ltd., bullish, Michael Myers
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.